Conferences
SUO 2017: Prostate Cancer Incidence, Treatment Trends, and Survival Among American Indians and Alaskan Natives in The U.S
December 1, 2017
SUO 2017: Neoadjuvant Therapies in Kidney Cancer: Critique, Current Trials and Future Directions
December 1, 2017
SUO 2017: Management of Immune-Related Toxicity with Checkpoint Inhibitors in Bladder Cancer Patients
December 1, 2017
SUO 2017: Metastasis-Free Survival Endpoint
December 1, 2017
SUO 2017: Bladder Cancer: Currently Approved Immunotherapy
December 1, 2017
SUO 2017: Biology and Management of MIBC and Oligometastatic Bladder Cancer – What is the Role of Surgery?
December 1, 2017
SUO 2017: Update on The Cancer Genome Atlas (TCGA)
December 1, 2017
SUO 2017: Biology and Management of MIBC and Oligometastatic Bladder Cancer – Clonal Evolution in Metastatic Urothelial Cancer
December 1, 2017
SUO 2017: Progression-Free Survival (PSA) Endpoint
December 1, 2017
SUO 2017: Genomic Analysis of Same-Patient Metachronous Upper-Tract and Bladder Urothelial Carcinoma
December 1, 2017
SUO 2017: Adjuvant Therapies in Kidney Cancer: Critique, Current Trials and Future Directions
December 1, 2017
SUO 2017: Neoadjuvant Versus Adjuvant Chemotherapy for MIBC: A Propensity Matched Analysis
December 1, 2017
SUO 2017: Objective Measures of Frailty as Predictors of Postoperative Complications After Radical Cystectomy
December 1, 2017
SUO 2017: APOBEC-Mediated Mutagenesis in Urothelial Carcinoma - Associated with Improved Survival
December 1, 2017